These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2490314)

  • 1. [Cellular and humoral mechanisms in graft rejection].
    Blanco A; Gómez-Carrasco JA
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():123-6. PubMed ID: 2490314
    [No Abstract]   [Full Text] [Related]  

  • 2. Basic mechanisms of humoral rejection.
    Cascalho M; Platt JL
    Pediatr Transplant; 2005 Feb; 9(1):9-16. PubMed ID: 15667605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of graft rejection].
    Kreisler JM
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():6-11. PubMed ID: 2490332
    [No Abstract]   [Full Text] [Related]  

  • 4. Posttransplant anti-HLA antibodies: risk factor for chronic rejection?
    Buchler M; al Najjar A; Guerraoui A; Valentin JF; Boulanger MD; Sherobeen R; Lataste A; Nivet H; Lebranchu Y
    Transplant Proc; 1995 Aug; 27(4):2478-9. PubMed ID: 7652894
    [No Abstract]   [Full Text] [Related]  

  • 5. The primacy of humoral antibody (complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity) in concordant xenograft rejection.
    Araneda D; Thomas FT; Ljung T; Cekada E; Pittman K
    Transplant Proc; 1995 Feb; 27(1):268-9. PubMed ID: 7878997
    [No Abstract]   [Full Text] [Related]  

  • 6. Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin.
    Schadde E; d'Alessandro AM; Musat AI; Torrealba JR; Knechtle SJ
    Clin Transpl; 2006; ():479-82. PubMed ID: 18365407
    [No Abstract]   [Full Text] [Related]  

  • 7. [Post-transplantation anti-HLA antibodies: which relevance?].
    Glotz D
    Nephrol Ther; 2008 Jun; 4 Suppl 1():S8-S12. PubMed ID: 18703400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-HLA antibody detection and rejection in kidney transplantation: impact of the new technologies].
    Georgescu D; Ferrari-Lacraz S; Villard J
    Rev Med Suisse; 2007 Apr; 3(108):1064-9. PubMed ID: 17552259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization.
    Kato T; Mizutani K; Terasaki P; Quintini C; Selvaggi G; Thompson J; Ruiz P; Tzakis A
    Transplant Proc; 2006; 38(6):1735-7. PubMed ID: 16908266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Generalities on the immunological mechanisms of graft rejection].
    Blancho G; Soulillou JP
    Rev Prat; 1991 Jun; 41(16):1505-8. PubMed ID: 1853117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transplantation of embryonic liver in severe combined immune deficiency].
    Shereshkov SI; Alekseev LP; Iartsev MN
    Ter Arkh; 1988; 60(5):36-42. PubMed ID: 3051487
    [No Abstract]   [Full Text] [Related]  

  • 13. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
    Lordon RE; Wilson RL; Shield CF; Ferrone S
    Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C4d-the witness of humoral rejection.
    de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
    Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which human leukocyte antigen antibodies are really clinically relevant?
    Opelz G; Claas FH
    Hum Immunol; 2009 Aug; 70(8):561-2. PubMed ID: 19580832
    [No Abstract]   [Full Text] [Related]  

  • 16. Humoral sensitization against rejected grafts: specific antibodies to graft immunogenic amino acid triplets.
    Iniotaki-Theodoraki A; Kalogeropoulou E; Apostolaki M; Doxiadis IN; Stavropoulos-Giokas C
    Transplant Proc; 2004; 36(6):1728-31. PubMed ID: 15350463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute humoral rejection in kidney transplantation with plasmapheresis.
    Grandtnerová B; Javorský P; Kolácný J; Hovoricová B; Dĕdic P; Laca L
    Transplant Proc; 1995 Feb; 27(1):934-5. PubMed ID: 7879238
    [No Abstract]   [Full Text] [Related]  

  • 18. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience.
    Mastrangelo F; Pretagostini R; Berloco P; Poli L; Cinti P; Patruno P; Alfonso L; Pompei L; Carboni F; Rizzelli S
    Transplant Proc; 1995 Feb; 27(1):892-5. PubMed ID: 7879221
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of protection from humoral rejection by a xenografted liver.
    Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.